IL1A and chronic myelogenous leukemia, BCR-ABL1 positive: In fact, in validation experiments, CML-AGE significantly induced Il1a expression, which was significantly reduced by pre-treatment with a RAGE inhibitor in BV2 cells (Supplemental Figure 5B) [32].